Plasma cell myeloma as one of the causes of bone pain in family medicine Opis przypadku

##plugins.themes.bootstrap3.article.sidebar##

PDF (English)


Opublikowane: maj 12, 2023
DOI: https://doi.org/10.24292/01.OR.131120523
Słowa kluczowe:
myeloma, hypercalcaemia, treatment

##plugins.themes.bootstrap3.article.main##

Grzegorz Kade
Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration's Hospital, Poland
Maciej Michalak
1. Diagnostic Imaging Department, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital, Olsztyn, Poland 2. Department of Radiology, University of Warmia and Mazury, Olsztyn, Poland
Bartosz Kade
Polyclinic – Primary Health Care, 10th Military Clinical Hospital in Bydgoszcz
Sebastian Spaleniak
Department of Internal Medicine and Nephrodiabetology, Medical University of Lodz, Poland
Agnieszka Podgórska
Department of Clinical Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital in Olsztyn, Poland
Janusz Hałka
Department of Clinical Hematology, Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration’s Hospital in Olsztyn, Poland

Abstrakt

The article draws attention to the need to maintain oncological vigilance in the daily practice of a family doctor. Diagnosis and effective treatment of hypercalcemia and plasma cell myeloma are presented.

Pobrania

Dane pobrania nie są jeszcze dostepne

##plugins.generic.paperbuzz.metrics##

##plugins.generic.paperbuzz.loading##

##plugins.themes.bootstrap3.article.details##

Jak cytować
1.
Kade G, Michalak M, Kade B, Spaleniak S, Podgórska A, Hałka J. Plasma cell myeloma as one of the causes of bone pain in family medicine. OncoReview [Internet]. 12 maj 2023 [cytowane 15 maj 2024];13(1(49):33-5. Dostępne na: https://journalsmededu.pl/index.php/OncoReview/article/view/2793
Numer
Tom 13 Nr 1(49) (2023)
Dział
ONCOWATCH. PRACTICAL CLINICAL IMAGES

Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)

Bibliografia

1. Tonon CR, Silva TAA L, Pereira FWL et al. A Review of Current Clinical Concepts in the Pathophysiology, Etiology, Diagnosis, and Management of Hypercalcemia. Med Sci Monit. 2022; 28: e935821. http://doi.org/10.12659/MSM.935821.
2. Andronowska E, Łozińska M, Rzeczkowska M et al. Multiple myeloma involving testes and bones. Pol Arch Intern Med. 2023; 133: 16371. http://doi.org/10.20452/pamw.16371.
3. Rosner MH, Dalkin AC. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin J Am Soc Nephrol. 2012; 7(10): 1722-9. http://doi.org/10.2215/CJN.02470312.
4. Hałka J, Spaleniak S, Michalak M et al. Solitary multiple myeloma as a very rare cause of hypophosphatemia, micturition, and defecation disorders. Pol Arch Intern Med. 2022; 132: 16259. http://doi.org/10.20452/pamw.16259.

Inne teksty tego samego autora